» Articles » PMID: 14527274

Molecular Pathogenicity of the Oral Opportunistic Pathogen Actinobacillus Actinomycetemcomitans

Overview
Publisher Annual Reviews
Specialty Microbiology
Date 2003 Oct 7
PMID 14527274
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Periodontitis is mankind's most common chronic inflammatory disease. One severe form of periodontitis is localized aggressive periodontitis (LAP), a condition to which individuals of African origin demonstrate an increased susceptibility. The main causative organism of this disease is Actinobacillus actinomycetemcomitans. A member of the Pasteurellaceae, A. actinomycetemcomitans produces a number of interesting putative virulence factors including (a) an RTX leukotoxin that targets only neutrophils and monocytes and whose action is influenced by a novel type IV secretion system involved in bacterial adhesion; (b) the newly discovered toxin, cytolethal distending toxin (CDT); and (c) a secreted chaperonin 60 with potent leukocyte-activating and bone resorbing activities. This organism also produces a plethora of proteins able to inhibit eukaryotic cell cycle progression and proteins and peptides that can induce distinct forms of proinflammatory cytokine networks. A range of other proteins interacting with the host is currently being uncovered. In addition to these secreted factors, A. actinomycetemcomitans is invasive with an unusual mechanism for entering, and traveling within, eukaryotic cells. This review focuses on recent advances in our understanding of the molecular and cellular pathogenicity of this fascinating oral bacterium.

Citing Articles

Influence of Photosensitizer on Photodynamic Therapy for Peri-Implantitis: A Systematic Review.

Schweigert T, Afonso J, da Palma R, Oliveira-Silva I, Silva C, Jirjos E Pharmaceutics. 2024; 16(3).

PMID: 38543201 PMC: 10975756. DOI: 10.3390/pharmaceutics16030307.


Antimicrobial effect against of advanced and injectable platelet-rich fibrin from patients with periodontal diseases versus periodontally healthy subjects.

Pham T, Tran T J Oral Biol Craniofac Res. 2023; 13(2):332-336.

PMID: 36937558 PMC: 10018549. DOI: 10.1016/j.jobcr.2023.02.011.


Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway.

Guo H, Ding D, Wang L, Yan J, Ma L, Jin Q PLoS One. 2021; 16(12):e0261127.

PMID: 34914744 PMC: 8675877. DOI: 10.1371/journal.pone.0261127.


An emphasis of T-cell subsets as regulators of periodontal health and disease.

Balaji S, Cholan P, Victor D J Clin Transl Res. 2021; 7(5):648-656.

PMID: 34778595 PMC: 8580519.


Lunate bone loss associated with infection.

Della Rosa N, Tosi D, Caserta G, Adani R Trauma Case Rep. 2021; 34:100431.

PMID: 34307820 PMC: 8283024. DOI: 10.1016/j.tcr.2021.100431.